Gsa Capital Partners LLP Kura Oncology, Inc. Transaction History

Gsa Capital Partners LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$8.44 - $11.86 $828,436 - $1.16 Million	-98,156 Reduced 89.89%	11,039 $100,000
Q2 2023 Aug 14, 2023	BUY	$9.62 - $13.99 $1.05 Million - $1.53 Million	109,195 New	109,195 $1.16 Million
Q3 2022 Nov 14, 2022	BUY	$12.01 - $19.45 $174,108 - $281,966	14,497 New	14,497 $198,000
Q1 2022 May 11, 2022	SELL	$11.78 - $16.98 $144,705 - $208,582	-12,284 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$12.22 - $19.57 $150,110 - $240,397	12,284 New	12,284 $172,000

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $603M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.